Sensus Healthcare stock fell by 1.86% while underperforming the Medical sector, analysts predict growth in revenue.

From Nasdaq: 2024-09-20 18:15:21

Sensus Healthcare, Inc. (SRTS) closed at $5.80, down 1.86% from the previous day, while the S&P 500 lost 0.19%. In the past month, the stock fell by 12.83%, underperforming the Medical sector. Analysts predict an EPS of -$0.02 and revenue of $5.84 million, showing growth compared to last year.

The Zacks Consensus Estimates for the full year suggest earnings of $0.36 per share and revenue of $36.98 million, marking significant changes from the previous year. Analysts are closely monitoring the company’s performance, and investors should pay attention to any revisions in estimates, which can signal business trends and profit potential.

Sensus Healthcare, Inc. holds a Zacks Rank of #2 (Buy) and has a Forward P/E ratio of 16.42, indicating potential valuation opportunity. The company is part of the Medical – Instruments industry, which ranks in the top 29% of all industries. Investors can find more information on Zacks.com regarding industry rankings and analysis.

Zacks Investment Research has identified 5 stocks set to double in 2024, with the potential for +100% gains. These picks are handpicked by experts and offer an opportunity for investors to get in early on stocks that may soar. Most of these stocks are flying under Wall Street’s radar, presenting a unique chance for growth.



Read more at Nasdaq: Sensus Healthcare, Inc. (SRTS) Falls More Steeply Than Broader Market: What Investors Need to Know